{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:15:34Z","timestamp":1790468134017,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A092042"],"award-info":[{"award-number":["A092042"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2010-0000593"],"award-info":[{"award-number":["2010-0000593"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bbrc.2010.11.132","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T04:20:54Z","timestamp":1291436454000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Secretases as therapeutic targets for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"404","author":[{"given":"Ha-Na","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Ha","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-Ryeong","family":"Gwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghee","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Kwang","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gyu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2010.11.132_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2010.11.132_b0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer\u2019s disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.132_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/13543784.16.1.59","article-title":"An update on pharmacological approaches to neurodegenerative diseases","volume":"16","author":"Scatena","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbrc.2010.11.132_b0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Alzheimer\u2019s disease","volume":"351","author":"Cummings","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2010.11.132_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.7.1.1","article-title":"Pharmacological strategies for the prevention of Alzheimer\u2019s disease","volume":"7","author":"Doraiswamy","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbrc.2010.11.132_b0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","article-title":"Alzheimer\u2019s disease: A[beta], tau and synaptic dysfunction","volume":"11","author":"LaFerla","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2010.11.132_b0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neurobiolaging.2005.05.022","article-title":"Intraneuronal A[beta] accumulation and origin of plaques in Alzheimer\u2019s disease","volume":"26","author":"Gouras","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2010.11.132_b0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2010.11.132_b0045","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1046\/j.1471-4159.1999.721417.x","article-title":"Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins Abeta1\u201340 and Abeta1\u201342, respectively","volume":"72","author":"Figueiredo-Pereira","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0050","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.11.132_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-4165(97)00139-6","article-title":"Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells","volume":"1380","author":"Michel","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2010.11.132_b0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1471-4159.2001.00037.x","article-title":"Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures","volume":"76","author":"Kuperstein","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1460-9568.2002.02056.x","article-title":"ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures","volume":"16","author":"Kuperstein","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2010.11.132_b0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","article-title":"Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17","volume":"282","author":"Hong","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.11.132_b0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2000.tb06911.x","article-title":"Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities","volume":"920","author":"Mailliot","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2010.11.132_b0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.11.132_b0085","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.132_b0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","article-title":"The Swedish mutation causes early-onset Alzheimer\u2019s disease by beta-secretase cleavage within the secretory pathway","volume":"1","author":"Haass","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.11.132_b0095","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.11.132_b0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00001756-199512000-00071","article-title":"A mutation in Alzheimer\u2019s disease destroying a splice acceptor site in the presenilin-1 gene","volume":"7","author":"Perez-Tur","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrc.2010.11.132_b0105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","article-title":"Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1\u201342\/1\u201340 ratio in vitro and in vivo","volume":"17","author":"Borchelt","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2010.11.132_b0110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.132_b0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","article-title":"Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics","volume":"43","author":"Selkoe","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2010.11.132_b0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nrn938","article-title":"Amyloid-beta immunotherapy for Alzheimer\u2019s disease: the end of the beginning","volume":"3","author":"Schenk","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2010.11.132_b0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/156720507781788882","article-title":"Alzhemed: a potential treatment for Alzheimer\u2019s disease","volume":"4","author":"Aisen","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbrc.2010.11.132_b0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/JMN:20:3:233","article-title":"Beta-secretase processing of the Alzheimer\u2019s amyloid protein precursor (APP)","volume":"20","author":"Marlow","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbrc.2010.11.132_b0135","doi-asserted-by":"crossref","first-page":"43756","DOI":"10.1074\/jbc.C100410200","article-title":"Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains","volume":"276","author":"Yu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0140","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2010.11.132_b0145","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1126\/science.1073844","article-title":"Biochemistry: intramembrane proteases\u2014mixing oil and water","volume":"296","author":"Wolfe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.11.132_b0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35017105","article-title":"Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells","volume":"2","author":"Herreman","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2010.11.132_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","article-title":"Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation","volume":"3","author":"Francis","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2010.11.132_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/35024009","article-title":"Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and betaAPP processing","volume":"407","author":"Yu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.132_b0300","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neulet.2009.12.043","article-title":"Contribution of gamma-secretase to calcium-mediated cell death","volume":"469","author":"Choi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2010.11.132_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0006-291X(03)00688-0","article-title":"Contribution of presenilin\/gamma-secretase to calsenilin-mediated apoptosis","volume":"305","author":"Jo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.11.132_b0175","doi-asserted-by":"crossref","first-page":"28135","DOI":"10.1074\/jbc.M110871200","article-title":"Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins","volume":"277","author":"Yang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0180","doi-asserted-by":"crossref","first-page":"52519","DOI":"10.1074\/jbc.C300435200","article-title":"Nicastrin interacts with gamma-secretase complex components via the N-terminal part of its transmembrane domain","volume":"278","author":"Capell","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0185","doi-asserted-by":"crossref","first-page":"16474","DOI":"10.1074\/jbc.C300095200","article-title":"Gamma-secretase activity is associated with a conformational change of nicastrin","volume":"278","author":"Shirotani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0190","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1074\/jbc.C200648200","article-title":"PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1","volume":"278","author":"Luo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0195","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature01506","article-title":"The role of presenilin cofactors in the gamma-secretase complex","volume":"422","author":"Takasugi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.132_b0200","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1021\/bi060799c","article-title":"The gamma-secretase complex: membrane-embedded proteolytic ensemble","volume":"45","author":"Wolfe","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2010.11.132_b0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tig.2007.01.008","article-title":"Presenilin diversifies its portfolio","volume":"23","author":"Parks","year":"2007","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2010.11.132_b0210","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbrc.2009.10.093","article-title":"Alzheimer\u2019s disease and Notch signaling","volume":"390","author":"Woo","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.11.132_b0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/35074581","article-title":"New protease inhibitors prevent gamma-secretase-mediated production of Abeta40\/42 without affecting Notch cleavage","volume":"3","author":"Petit","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2010.11.132_b0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nm1403","article-title":"Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke","volume":"12","author":"Arumugam","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.11.132_b0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","article-title":"Identification of a novel aspartic protease (Asp 2) as beta-secretase","volume":"14","author":"Hussain","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2010.11.132_b0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.11.132_b0235","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"Sinha","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.11.132_b0305","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neurobiolaging.2008.07.003","article-title":"Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer\u2019s disease","volume":"31","author":"Jo","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2010.11.132_b0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2007.05072.x","article-title":"Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein","volume":"104","author":"Tamagno","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/85059","article-title":"Mice deficient in BACE1, the Alzheimer\u2019s beta-secretase, have normal phenotype and abolished beta-amyloid generation","volume":"4","author":"Luo","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2010.11.132_b0255","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","article-title":"BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer\u2019s disease therapeutics","volume":"10","author":"Roberds","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2010.11.132_b0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/156802606776743084","article-title":"Human beta-secretase (BACE) and BACE inhibitors: progress report","volume":"6","author":"John","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0006-291X(02)02999-6","article-title":"Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase","volume":"301","author":"Asai","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.11.132_b0270","doi-asserted-by":"crossref","first-page":"27765","DOI":"10.1074\/jbc.273.43.27765","article-title":"Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor","volume":"273","author":"Buxbaum","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ab.2005.04.019","article-title":"Biochemical and cell-based assays for characterization of BACE-1 inhibitors","volume":"342","author":"Pietrak","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1471-4159.2003.02298.x","article-title":"Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein","volume":"89","author":"Laudon","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0285","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1074\/jbc.C100649200","article-title":"A sensitive and quantitative assay for measuring cleavage of presenilin substrates","volume":"277","author":"Karlstrom","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.11.132_b0290","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2004.12.078","article-title":"Overexpression of calsenilin enhances gamma-secretase activity","volume":"378","author":"Jo","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2010.11.132_b0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jnr.490380111","article-title":"Study of the phorbol ester effect on Alzheimer amyloid precursor processing: sequence requirements and involvement of a cholera toxin sensitive protein","volume":"38","author":"Efthimiopoulos","year":"1994","journal-title":"J. Neurosci. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10022072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10022072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:52:02Z","timestamp":1757760722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X10022072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0006291X10022072"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.11.132","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secretases as therapeutic targets for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.11.132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}